Abu Dhabi’s G42 Healthcare has signed a preliminary agreement with Israel’s NanoScent to develop, distribute, and manufacture a COVID-19 test that can detect positive cases of the coronavirus from exhaled nasal air, the UAE state news agency WAM has reported.
Named Scent Check, the device works by reportedly detecting “a combination of volatile organic compounds – or ‘VOC Signature’,” from...
